Literature DB >> 9231211

The disposition of intramuscular artemether in children with cerebral malaria; a preliminary study.

S A Murphy1, E Mberu, D Muhia, M English, J Crawley, C Waruiru, B Lowe, C R Newton, P Winstanley, K Marsh, W M Watkins.   

Abstract

The disposition of intramuscular artemether (AM) was studied in 26 Kenyan children with cerebral malaria. Antimalarial activity determined by bioassay was compared with total plasma AM plus dihydroartemisinin (DHA) determined by high power liquid chromatography (HPLC). Therapeutic levels were achieved in most subjects (21/26) within 1 h of receiving intramuscular AM (3.2 mg/kg), with close correlation between bioassay and HPLC measurements (r = 0.706). However, there was marked inter-individual variation, antimalarial activity was undetectable in 5 subjects ('non-absorbers'), and plasma concentrations were lower in subject with respiratory distress. The 50% parasite clearance time was significantly longer in non-absorbers (mean = 13.1 h, SD = 10.8 vs. mean = 7.8 h, SD = 5.5; P = 0.013). We conclude that the bioavailability of intramuscular AM in children with severe malaria may be highly variable, particularly in the presence of respiratory distress, and may be associated with an inadequate therapeutic response.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9231211     DOI: 10.1016/s0035-9203(97)90097-3

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  20 in total

Review 1.  Cerebral malaria.

Authors:  C R Newton; T T Hien; N White
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-10       Impact factor: 10.154

2.  Artemether for severe malaria.

Authors:  Ekpereonne B Esu; Emmanuel E Effa; Oko N Opie; Martin M Meremikwu
Journal:  Cochrane Database Syst Rev       Date:  2019-06-18

3.  Dose-finding and efficacy study for i.m. artemotil (beta-arteether) and comparison with i.m. artemether in acute uncomplicated P. falciparum malaria.

Authors:  S Looareesuwan; B Oosterhuis; B M Schilizzi; F A E Sollie; P Wilairatana; S Krudsood; Ch B Lugt; P A M Peeters; J O Peggins
Journal:  Br J Clin Pharmacol       Date:  2002-05       Impact factor: 4.335

4.  Comparative pharmacokinetics of intramuscular artesunate and artemether in patients with severe falciparum malaria.

Authors:  T T Hien; T M E Davis; L V Chuong; K F Ilett; D X T Sinh; N H Phu; C Agus; G M Chiswell; N J White; J Farrar
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

Review 5.  Management of severe malaria.

Authors:  Tanu Singhal
Journal:  Indian J Pediatr       Date:  2004-01       Impact factor: 1.967

6.  Randomized controlled trial of artesunate or artemether in Vietnamese adults with severe falciparum malaria.

Authors:  Nguyen H Phu; Phung Q Tuan; Nicholas Day; Nguyen T H Mai; Tran T H Chau; Ly V Chuong; Dinh X Sinh; Nicholas J White; Jeremy Farrar; Tran T Hien
Journal:  Malar J       Date:  2010-04-15       Impact factor: 2.979

7.  Artesunate suppositories versus intramuscular artemether for treatment of severe malaria in children in Papua New Guinea.

Authors:  Harin A Karunajeewa; John Reeder; Kerry Lorry; Elizah Dabod; Juliana Hamzah; Madhu Page-Sharp; Gregory M Chiswell; Kenneth F Ilett; Timothy M E Davis
Journal:  Antimicrob Agents Chemother       Date:  2006-03       Impact factor: 5.191

8.  Artemether bioavailability after oral or intramuscular administration in uncomplicated falciparum malaria.

Authors:  Kamolrat Silamut; Paul N Newton; Paktiya Teja-Isavadharm; Yupin Suputtamongkol; Duangsuda Siriyanonda; Maneerat Rasameesoraj; Sasithon Pukrittayakamee; Nicholas J White
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

9.  Penetration of dihydroartemisinin into cerebrospinal fluid after administration of intravenous artesunate in severe falciparum malaria.

Authors:  Timothy M E Davis; Tran Quang Binh; Kenneth F Ilett; Kevin T Batty; Hoang Lan Phuöng; Gregory M Chiswell; Vu Duong Bich Phuong; Cindy Agus
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

10.  Population pharmacokinetics of artemether and dihydroartemisinin following single intramuscular dosing of artemether in African children with severe falciparum malaria.

Authors:  Sadik Mithwani; Leon Aarons; Gilbert O Kokwaro; Oneeb Majid; Simon Muchohi; Geoffrey Edwards; Sumia Mohamed; Kevin Marsh; William Watkins
Journal:  Br J Clin Pharmacol       Date:  2004-02       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.